PepDiana
Back to Evidence
Primary experimental recordPositive observation

PMC10004598::ACT000052

P1

Evidence text

Paper-level observation

Table 3: Hemolysis of human erythrocytes by Hydrostatin-AMP2 is 4.6%.
tableConfidence: medium

Assay observation

Activity
Toxicity
Subtype
Hemolytic
Measure
hemolysis
Comparator
=
Raw observation
4.6%
Normalized measurement
=4.6%
Value minimum
Not reported by source
Value maximum
Not reported by source
Target
Homo sapiens
Assay method
Not reported by source
Sequence
KRFKKFFKKLRKSVKKRVKKFFKKPKVIGVSIPF
Standardization
ready simple

Source publication

Identification and Characterization of a Novel Cathelicidin from Hydrophis cyanocinctus with Antimicrobial and Anti-Inflammatory Activity

Molecules · 2023

DOI 10.3390/molecules28052082 PMC10004598
Parent mention Integrated peptide

Related peptide identities

PEPDIA-PLP-003777PEPDIA-INT-004630

Release PepDiana-V1-20260620. The stable record URL can be cited directly in supplementary material and downstream analyses.